Ameriprise Financial Inc. Increases Stock Holdings in Agilent Technologies, Inc. $A

Ameriprise Financial Inc. lifted its stake in shares of Agilent Technologies, Inc. (NYSE:A) by 15.1% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 2,708,591 shares of the medical research company’s stock after purchasing an additional 354,480 shares during the quarter. Ameriprise Financial Inc. owned about 0.96% of Agilent Technologies worth $347,685,000 at the end of the most recent quarter.

Several other hedge funds have also recently modified their holdings of the stock. Capital A Wealth Management LLC raised its holdings in Agilent Technologies by 10,600.0% during the second quarter. Capital A Wealth Management LLC now owns 214 shares of the medical research company’s stock worth $25,000 after purchasing an additional 212 shares in the last quarter. Davis Capital Management purchased a new stake in Agilent Technologies in the 3rd quarter valued at approximately $28,000. Physician Wealth Advisors Inc. increased its position in Agilent Technologies by 490.0% during the 3rd quarter. Physician Wealth Advisors Inc. now owns 236 shares of the medical research company’s stock worth $30,000 after purchasing an additional 196 shares during the period. State of Wyoming purchased a new position in shares of Agilent Technologies during the 2nd quarter worth approximately $35,000. Finally, SJS Investment Consulting Inc. raised its stake in shares of Agilent Technologies by 2,836.4% during the 3rd quarter. SJS Investment Consulting Inc. now owns 323 shares of the medical research company’s stock worth $41,000 after buying an additional 312 shares in the last quarter.

Agilent Technologies Stock Up 0.3%

Shares of NYSE:A opened at $111.88 on Tuesday. The company has a quick ratio of 1.59, a current ratio of 2.07 and a debt-to-equity ratio of 0.44. The company has a market capitalization of $31.62 billion, a P/E ratio of 24.70, a P/E/G ratio of 2.35 and a beta of 1.31. Agilent Technologies, Inc. has a 52-week low of $96.43 and a 52-week high of $160.27. The stock’s fifty day simple moving average is $129.72 and its 200-day simple moving average is $135.85.

Agilent Technologies (NYSE:A) last posted its quarterly earnings data on Wednesday, February 25th. The medical research company reported $1.36 EPS for the quarter, missing analysts’ consensus estimates of $1.37 by ($0.01). Agilent Technologies had a return on equity of 24.49% and a net margin of 18.26%.The company had revenue of $1.80 billion for the quarter, compared to analysts’ expectations of $1.81 billion. During the same quarter in the prior year, the business posted $1.31 EPS. The company’s revenue for the quarter was up 7.0% compared to the same quarter last year. Agilent Technologies has set its FY 2026 guidance at 5.900-6.040 EPS and its Q2 2026 guidance at 1.390-1.420 EPS. As a group, equities research analysts forecast that Agilent Technologies, Inc. will post 5.58 earnings per share for the current fiscal year.

Agilent Technologies Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, April 22nd. Shareholders of record on Tuesday, March 31st will be issued a $0.255 dividend. The ex-dividend date is Tuesday, March 31st. This represents a $1.02 annualized dividend and a yield of 0.9%. Agilent Technologies’s payout ratio is 22.52%.

Analyst Upgrades and Downgrades

A number of analysts recently weighed in on the company. UBS Group decreased their price target on Agilent Technologies from $180.00 to $165.00 and set a “buy” rating on the stock in a research note on Thursday, February 26th. Citigroup increased their price objective on Agilent Technologies from $165.00 to $185.00 and gave the stock a “buy” rating in a research report on Tuesday, November 25th. Robert W. Baird raised their target price on Agilent Technologies from $142.00 to $165.00 and gave the company an “outperform” rating in a report on Tuesday, November 25th. Weiss Ratings restated a “hold (c+)” rating on shares of Agilent Technologies in a research report on Monday, December 29th. Finally, TD Cowen lowered their price target on shares of Agilent Technologies from $170.00 to $157.00 and set a “buy” rating on the stock in a research note on Thursday, February 26th. Two investment analysts have rated the stock with a Strong Buy rating, eleven have assigned a Buy rating and three have given a Hold rating to the stock. Based on data from MarketBeat.com, Agilent Technologies currently has a consensus rating of “Moderate Buy” and a consensus price target of $161.20.

About Agilent Technologies

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.